Abscopal but desirable: The contribution of immune responses to the efficacy of radiotherapy.
about
The Concept of Hormesis in Cancer Therapy - Is Less More?Radiotherapy and the tumor stroma: the importance of dose and fractionationAt the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy.Trial watch: Immunostimulatory cytokines in cancer therapy.Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer.Cancer-associated fibroblasts from lung tumors maintain their immunosuppressive abilities after high-dose irradiation.Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction.Cross-talk between tumors can affect responses to therapyImmunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation.Immunotherapeutic strategies to target prognostic and predictive markers of cancer.Modulation of dendritic cell function by the radiation-mediated secretory protein γ-synuclein.The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.Dendritic cell-based approaches in the fight against diseases.Therapeutic vaccines for cancer: an overview of clinical trials.Transmission of signals from rats receiving high doses of microbeam radiation to cage mates: an inter-mammal bystander effectImpact of the immune system and immunotherapy in colorectal cancer.Emerging immunotherapy for the treatment of esophageal cancer.Immune checkpoint inhibitors in gynecologic cancers with lessons learned from non-gynecologic cancers.Immune checkpoint inhibitor combinations in solid tumors: opportunities and challengesImmunogenic potential of irradiated lymphoma cells is enhanced by adjuvant immunotherapy and modulation of local macrophage populations.TLR activation and ionizing radiation induce strong immune responses against multiple tumor entities.Local immunomodulation for cancer therapy: Providing treatment where neededImmunogenic cell death in radiation therapyRadiation fosters dose-dependent and chemotherapy-induced immunogenic cell death.New immunotherapeutic paradigms for castration-resistant prostate cancer.Trial Watch: Anticancer radioimmunotherapy.Trial watch: Dendritic cell-based interventions for cancer therapy.Trial Watch: Radioimmunotherapy for oncological indications.Trial Watch: Chemotherapy with immunogenic cell death inducers.Treatment of glioblastoma in adults
P2860
Q26800519-1FC4234C-8217-4287-8461-4CDD808D33A2Q27022685-DF5BED02-DDF2-4E2B-BAC0-7EEAD1140785Q33732329-247B8F53-5CC7-47DD-A456-EAB6DEFF61AFQ33880165-45B674B2-E63C-4BEF-9126-1CD272A124FBQ34333155-C9F8CADB-6913-49E3-AA37-AC63C6764A2FQ35598951-0687ECD0-A496-4ED0-AFBE-3899F7AF3460Q35670632-C2522556-6A53-43CC-B6C6-A266702A7B66Q35799079-4FA60D4D-61EA-4293-92C1-F00FEFC5CE3FQ36985164-441193CB-7DB1-4E84-8BB2-6E77392FB413Q37126006-B508BE77-1294-4B5A-BAA4-7113C6D2043BQ37164196-E91DCC4D-2021-4F74-AE01-DFBA30FFCDCFQ37706254-F438F1FD-0A08-4D0C-B4FD-61AC3DB19BF9Q38195040-F2E0860B-E034-424F-A8B4-38BB0D0EDCCCQ38227030-B6D05914-8E0C-4E68-B0FC-A3716A994476Q38370262-8D93FE48-C97A-464F-B2FF-973B1CA08E8FQ38398877-91471B5D-B7D6-4994-98E6-B0740B1C3731Q38763851-0A8E723E-D080-493B-B833-72F37A6DA33AQ38806038-CB7D8B7E-3E48-494F-851F-57C167F9BCDAQ38878906-D802787F-70F4-4E3D-A482-3374792F0BFCQ39206813-A746A720-15B9-4107-8BE9-D9FE666212B8Q41578773-489E658B-3541-4CD1-9337-704F34B538A3Q41830647-BC7A5640-6DA6-4AC0-A7AE-343343742307Q41852251-EA9F1235-7DDA-484A-A3BE-5EE4A084CBBBQ42115292-B5221AB0-7D7A-4521-9807-CE7BE98DC528Q42344607-1262D195-AB56-4BC9-8D12-C46A260AF552Q42847992-C4BB5526-1980-4E72-9B5E-D1204E332430Q42867339-C315D5BB-BFAE-4FF4-B580-141FD1A00681Q43104064-7272D9AA-74D7-4B1C-8AEC-C194D8035360Q55260834-A1D3B543-EB18-407C-8EC9-41897BC962E5Q57174802-DBB805F6-ACDC-4721-BF70-F5D8ADDAEC3E
P2860
Abscopal but desirable: The contribution of immune responses to the efficacy of radiotherapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Abscopal but desirable: The co ...... the efficacy of radiotherapy.
@en
Abscopal but desirable: The co ...... the efficacy of radiotherapy.
@nl
type
label
Abscopal but desirable: The co ...... the efficacy of radiotherapy.
@en
Abscopal but desirable: The co ...... the efficacy of radiotherapy.
@nl
prefLabel
Abscopal but desirable: The co ...... the efficacy of radiotherapy.
@en
Abscopal but desirable: The co ...... the efficacy of radiotherapy.
@nl
P2860
P356
P1433
P1476
Abscopal but desirable: The co ...... the efficacy of radiotherapy.
@en
P2860
P304
P356
10.4161/ONCI.20074
P577
2012-07-01T00:00:00Z